Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations
about
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityRectal pre-exposure prophylaxis (PrEP)Development of HIV-1 rectal-specific microbicides and colonic tissue evaluationUse of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.Rectal microbicide development.Evaluation of degradation kinetics and physicochemical stability of tenofovirDevelopment of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention.The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCGFactors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1Reformulated tenofovir gel for use as a dual compartment microbicide.Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates.A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02).The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection.Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.The development of rectal microbicides for HIV prevention.
P2860
Q21133918-3B020AA7-46A6-4C42-A888-85387E8E1D5FQ26829713-ECE52E68-9FB3-4738-9DBA-3D42C4778C76Q28540761-1C53D88F-6261-415F-9F33-21985928F761Q34566597-D7C061D8-8DD3-439D-8884-88CBDE9F8C92Q34575590-C3079662-6EDB-4501-80D9-0D0B79523280Q34785122-8E45A224-198A-46A6-99B8-CC964E186FB9Q35701205-10917234-2104-4486-ADDB-EFE3ED32F7A6Q35822713-3A0717BD-E0B1-4EBB-A824-CCD3A2725278Q35842343-18669E9A-1B13-4F97-97E5-F8491C1A4FE0Q36111516-4B19AF4C-E8A4-4FC9-91C2-5A1BA0617AD2Q36159765-1415C8BD-653C-4CA0-9A75-D5BA86F03A53Q36294765-73555824-6851-46E4-B306-6B0AC097C071Q36294792-5CD2086D-AC9F-4041-872E-BA6FC025FD68Q36359133-FDDAAA1E-B39F-4DBE-BF81-175EEC91B814Q37707803-985852B8-1CD7-44AF-BF6F-785522423358Q38165222-2A091970-27EF-4D03-8A8F-0A68FEC2EC2A
P2860
Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rectal microbicides: clinicall ...... specific placebo formulations
@ast
Rectal microbicides: clinicall ...... specific placebo formulations
@en
Rectal microbicides: clinicall ...... specific placebo formulations
@nl
type
label
Rectal microbicides: clinicall ...... specific placebo formulations
@ast
Rectal microbicides: clinicall ...... specific placebo formulations
@en
Rectal microbicides: clinicall ...... specific placebo formulations
@nl
prefLabel
Rectal microbicides: clinicall ...... specific placebo formulations
@ast
Rectal microbicides: clinicall ...... specific placebo formulations
@en
Rectal microbicides: clinicall ...... specific placebo formulations
@nl
P2093
P2860
P356
P1476
Rectal microbicides: clinicall ...... specific placebo formulations
@en
P2093
Lisa C Rohan
Peter A Anton
Roger L Schnaare
P2860
P2888
P356
10.1186/1742-6405-8-12
P577
2011-03-07T00:00:00Z
P5875
P6179
1032773351